One-year efficacy and safety of policosanol in patients with type II hypercholesterolemia
- 1 September 1994
- journal article
- Published by Elsevier in Current Therapeutic Research
- Vol. 55 (9) , 1084-1092
- https://doi.org/10.1016/s0011-393x(05)80279-6
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- A 12-month study of policosanol oral toxicity in Sprague Dawley ratsToxicology Letters, 1994
- Effect of successive dose increases of policosanol on the lipid profile and tolerability of treatmentCurrent Therapeutic Research, 1993
- Efficacy and safety of policosanol in patients with primary hypercholesterolemiaCurrent Therapeutic Research, 1992
- Extended clinical safety profile of lovastatinThe American Journal of Cardiology, 1990
- Lipid lowering drugs.BMJ, 1990
- Efficacy and long-term adverse effect pattern of lovastatinThe American Journal of Cardiology, 1988
- An Overview of Lipid-Lowering DrugsDrugs, 1988
- The Lipid Research Clinics Coronary Primary Prevention Trial ResultsJAMA, 1984
- The Lipid Research Clinics Coronary Primary Prevention Trial ResultsJAMA, 1984
- Competitive inhibition of 3‐hydroxy‐3‐methylglutaryl coenzyme a reductase by ML‐236A and ML‐236B fungal metabolites, having hypocholesterolemic activityFEBS Letters, 1976